MeCP2 Regulates the Synaptic Expression of a Dysbindin-BLOC-1 Network Component in Mouse Brain and Human Induced Pluripotent Stem Cell-Derived Neurons

Larimore, Jennifer; Ryder, Pearl V.; Kim, Kun-Yong; Ambrose, L. Alex; Chapleau, Christopher; Calfa, Gaston; Gross, Christina; Bassell, Gary J.; Pozzo-Miller, Lucas; Smith, Yoland; Talbot, Konrad; Park, In-Hyun; Faundez, Victor
June 2013
PLoS ONE;Jun2013, Vol. 8 Issue 6, p1
Academic Journal
Clinical, epidemiological, and genetic evidence suggest overlapping pathogenic mechanisms between autism spectrum disorder (ASD) and schizophrenia. We tested this hypothesis by asking if mutations in the ASD gene MECP2 which cause Rett syndrome affect the expression of genes encoding the schizophrenia risk factor dysbindin, a subunit of the biogenesis of lysosome-related organelles complex-1 (BLOC-1), and associated interacting proteins. We measured mRNA and protein levels of key components of a dysbindin interaction network by, quantitative real time PCR and quantitative immunohistochemistry in hippocampal samples of wild-type and Mecp2 mutant mice. In addition, we confirmed results by performing immunohistochemistry of normal human hippocampus and quantitative qRT-PCR of human inducible pluripotent stem cells (iPSCs)-derived human neurons from Rett syndrome patients. We defined the distribution of the BLOC-1 subunit pallidin in human and mouse hippocampus and contrasted this distribution with that of symptomatic Mecp2 mutant mice. Neurons from mutant mice and Rett syndrome patients displayed selectively reduced levels of pallidin transcript. Pallidin immunoreactivity decreased in the hippocampus of symptomatic Mecp2 mutant mice, a feature most prominent at asymmetric synapses as determined by immunoelectron microcopy. Pallidin immunoreactivity decreased concomitantly with reduced BDNF content in the hippocampus of Mecp2 mice. Similarly, BDNF content was reduced in the hippocampus of BLOC-1 deficient mice suggesting that genetic defects in BLOC-1 are upstream of the BDNF phenotype in Mecp2 deficient mice. Our results demonstrate that the ASD-related gene Mecp2 regulates the expression of components belonging to the dysbindin interactome and these molecular differences may contribute to synaptic phenotypes that characterize Mecp2 deficiencies and ASD.


Related Articles

  • Alteration in basal and depolarization induced transcriptional network in iPSC derived neurons from Timothy syndrome. Yuan Tian; Voineagu, Irina; Pasca, Sergiu P.; Hyejung Won; Chandran, Vijayendran; Horvath, Steve; Dolmetsch, Ricardo E.; Geschwind, Daniel H. // Genome Medicine;2014, Vol. 6 Issue 10, p1 

    Background Common genetic variation and rare mutations in genes encoding calcium channel subunits have pleiotropic effects on risk for multiple neuropsychiatric disorders, including autism spectrum disorder (ASD) and schizophrenia. To gain further mechanistic insights by extending previous gene...

  • Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro. Tanaka, Akihito; Woltjen, Knut; Miyake, Katsuya; Hotta, Akitsu; Ikeya, Makoto; Yamamoto, Takuya; Nishino, Tokiko; Shoji, Emi; Sehara-Fujisawa, Atsuko; Manabe, Yasuko; Fujii, Nobuharu; Hanaoka, Kazunori; Era, Takumi; Yamashita, Satoshi; Isobe, Ken-ichi; Kimura, En; Sakurai, Hidetoshi // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    The establishment of human induced pluripotent stem cells (hiPSCs) has enabled the production of in vitro, patient-specific cell models of human disease. In vitro recreation of disease pathology from patient-derived hiPSCs depends on efficient differentiation protocols producing relevant adult...

  • Profiling parvalbumin interneurons using iPSC: challenges and perspectives for Autism Spectrum Disorder (ASD). Filice, Federica; Schwaller, Beat; Michel, Tanja M.; Grünblatt, Edna // Molecular Autism;1/29/2020, Vol. 11 Issue 1, p1 

    Autism spectrum disorders (ASD) are persistent conditions resulting from disrupted/altered neurodevelopment. ASD multifactorial etiology—and its numerous comorbid conditions—heightens the difficulty in identifying its underlying causes, thus obstructing the development of effective...

  • Great Expectations: Autism Spectrum Disorder and Induced Pluripotent Stem Cell Technologies. Liu, Emily; Scott, Christopher // Stem Cell Reviews & Reports;Apr2014, Vol. 10 Issue 2, p145 

    New applications of iPSC technology to research on complex idiopathic conditions raise several important ethical and social considerations for potential research participants and their families. In this short review, we examine these issues through the lens of emerging research on autism...

  • KSR-Based Medium Improves the Generation of High-Quality Mouse iPS Cells. Liu, Kai; Wang, Fang; Ye, Xiaoying; Wang, Lingling; Yang, Jiao; Zhang, Jingzhuo; Liu, Lin // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Induced pluripotent stem (iPS) cells from somatic cells have great potential for regenerative medicine. The efficiency in generation of iPS cells has been significantly improved in recent years. However, the generation of high-quality iPS cells remains of high interest. Consistently, we...

  • Human iPS Cell-Derived Insulin Producing Cells Form Vascularized Organoids under the Kidney Capsules of Diabetic Mice. Raikwar, Sudhanshu P.; Kim, Eun-Mi; Sivitz, William I.; Allamargot, Chantal; Thedens, Daniel R.; Zavazava, Nicholas // PLoS ONE;Jan2015, Vol. 10 Issue 1, p1 

    Type 1 diabetes (T1D) is caused by autoimmune disease that leads to the destruction of pancreatic β-cells. Transplantation of cadaveric pancreatic organs or pancreatic islets can restore normal physiology. However, there is a chronic shortage of cadaveric organs, limiting the treatment of the...

  • Efficient Generation of Virus-Free iPS Cells Using Liposomal Magnetofection. Hyo Young Park; Eun Hyung Noh; Hyung-Min Chung; Man-Jong Kang; Eun Young Kim; Se Pill Park; Ceña, Valentin // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    The generation of induced pluripotent stem (iPS) cells is a powerful tool in regenerative medicine, and advances in nanotechnology clearly have great potential to enhance stem cell research. Here, we introduce a liposomal magnetofection (LMF) method for iPS cell generation. Efficient conditions...

  • Vector-Free and Transgene-Free Human iPS Cells Differentiate into Functional Neurons and Enhance Functional Recovery after Ischemic Stroke in Mice Mohamad, Osama; Drury-Stewart, Danielle; Song, Mingke; Faulkner, Ben; Chen, Dongdong; Yu, Shan Ping; Wei, Ling // PLoS ONE;May2013, Vol. 8 Issue 5, p1 

    Stroke is a leading cause of human death and disability in the adult population in the United States and around the world. While stroke treatment is limited, stem cell transplantation has emerged as a promising regenerative therapy to replace or repair damaged tissues and enhance functional...

  • Generation and Characterization of Induced Pluripotent Stem Cells from Aid-Deficient Mice. Shimamoto, Ren; Amano, Naoki; Ichisaka, Tomoko; Watanabe, Akira; Yamanaka, Shinya; Okita, Keisuke // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    It has been shown that DNA demethylation plays a pivotal role in the generation of induced pluripotent stem (iPS) cells. However, the underlying mechanism of this action is still unclear. Previous reports indicated that activation-induced cytidine deaminase (Aid, also known as Aicda) is involved...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics